» Articles » PMID: 37759103

Are We Nearly There Yet? Starts and Stops on the Road to Use of Polygenic Scores

Overview
Publisher Springer
Specialty Health Services
Date 2023 Sep 27
PMID 37759103
Authors
Affiliations
Soon will be listed here.
References
1.
Riddle L, Joseph G, Caruncho M, Koenig B, James J . The role of polygenic risk scores in breast cancer risk perception and decision-making. J Community Genet. 2023; 14(5):489-501. PMC: 10576692. DOI: 10.1007/s12687-023-00655-x. View

2.
Koch S, Schmidtke J, Krawczak M, Caliebe A . Clinical utility of polygenic risk scores: a critical 2023 appraisal. J Community Genet. 2023; 14(5):471-487. PMC: 10576695. DOI: 10.1007/s12687-023-00645-z. View

3.
Mason A, Obi I, Ayodele O, Lambert S, Fahle S . What makes a good life: using theatrical performance to enhance communication about polygenic risk scores research in patient and public involvement. J Community Genet. 2023; 14(5):453-458. PMC: 10576689. DOI: 10.1007/s12687-023-00635-1. View

4.
Pashayan N, Easton D, Michailidou K . Polygenic risk scores in cancer screening: a glass half full or half empty?. Lancet Oncol. 2023; 24(6):579-581. DOI: 10.1016/S1470-2045(23)00217-6. View

5.
Johnston J, Matthews L . Polygenic embryo testing: understated ethics, unclear utility. Nat Med. 2022; 28(3):446-448. PMC: 9208380. DOI: 10.1038/s41591-022-01743-0. View